Completed

Randomized Clinical Trial in Juvenile Fibromyalgia

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Coping Skills Training

+ Education

Behavioral
Who is being recruted

Fibromyalgia+8

+ Muscular Diseases

+ Musculoskeletal Diseases

From 11 to 18 Years
+8 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Phase 3
Interventional
Study Start: July 2004
See protocol details

Summary

Principal SponsorChildren's Hospital Medical Center, Cincinnati
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: July 1, 2004

Actual date on which the first participant was enrolled.

Juvenile Primary Fibromyalgia Syndrome (JPFS) is a debilitating chronic pain condition that occurs in adolescence and is characterized by persistent pain, multiple tender points, sleep difficulty, and fatigue. The cause of JPFS is unknown and there is no known cure. Children and adolescents with JPFS have difficulty with daily functioning, miss a great deal of school, and experience increased emotional distress compared to their peers. Fibromyalgia syndrome appears to be resistant to treatment in adulthood, so early behavioral treatment for JPFS with long-term beneficial effects would be useful. This study will evaluate the efficacy of coping skills training (CST) when combined with usual medical care in reducing functional disability, pain intensity, and depressive symptoms in adolescents with JPFS. This study will also determine whether improvements can be sustained long-term. This study will last 34 weeks. Participants will be recruited from three pediatric rheumatology clinics. Patients will be randomly assigned to one of two groups: CST plus usual medical care or education plus usual medical care. There will be 6 medical visits, spaced 4 to 5 weeks apart. In addition, patients will attend 8 individual sessions of CST or education over the first 8 weeks of the study. CST sessions will include training in cognitive-behavioral techniques of pain management for the adolescent and behavioral management techniques for their parents. Education sessions will include education on fibromyalgia and discussion about lifestyle issues, but no training in pain management procedures. Patients will be evaluated at Week 9 and will be followed for an additional 6-month maintenance phase. During this maintenance phase, adolescents will continue to receive their usual medical care and will attend 2 additional sessions of CST or education. There will be one final evaluation at the end of the maintenance phase.

Official TitleRandomized Clinical Trial in Juvenile Fibromyalgia
NCT00086047
Principal SponsorChildren's Hospital Medical Center, Cincinnati
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

114 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.



Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 11 to 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

FibromyalgiaMuscular DiseasesMusculoskeletal DiseasesNervous System DiseasesNeurologic ManifestationsNeuromuscular DiseasesPainRheumatic DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsChronic Pain

Criteria

4 inclusion criteria required to participate
Diagnosis of JPFS based upon widespread pain for over 3 months, at least 5 tender points, and associated features such as sleep difficulty, fatigue, and abdominal discomfort

Average pain intensity greater than 4 on the Visual Analog Scale

Functional disability score greater than 7

Stable medications for 8 weeks prior to study entry

4 exclusion criteria prevent from participating
Other chronic rheumatic diseases, such as juvenile rheumatoid arthritis or lupus

Significant developmental delay or impairments, such as autism, cerebral palsy, or mental retardation

Present or lifetime psychiatric diagnosis that meets DSM-IV criteria for panic disorder, bipolar disorder, major depressive disorder, or psychosis

Opioid medications are disallowed when used on an ongoing basis for treatment of fibromyalgia pain

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
Patients will receive 8 weeks of behavioral training in pain coping strategies

Group II

Active Comparator
Patient will receive 8 weekly sessions of education about fibromyalgia syndrome.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 3 locations

Suspended

Kosair Charities Pediatric Center

Louisville, United StatesOpen Kosair Charities Pediatric Center in Google Maps
Suspended

Cincinnati Children's Hospital Medical Center

Cincinnati, United States
Suspended

Cleveland Clinic Foundation, Division of Pediatrics

Cleveland, United States
Completed3 Study Centers